Internal Medicine Doctors in Springville, NY Accepting Medicare
5 Internal Medicine doctors found. Showing 1 - 5
 Dr. Priscilla K Dale, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 210 E Main St, Springville, NY 14141 Phone: 716-592-3600 Fax: 716-592-2929 |
Dr. Lisette Anne D'eon, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 224 E Main St, Bertrand Chaffee Hospital Primary Care Clinic, Springville, NY 14141 Phone: 716-592-8140 Fax: 716-961-3713 |
 Dr. William Joseph Wnuk, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 E Main St, Springville, NY 14141 Phone: 716-592-3635 Fax: 716-592-2929 |
Dr. Edwin Heidelberger, MD PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 E Main St, Springville, NY 14141 Phone: 716-592-3635 Fax: 716-592-2929 |
Dr. Patrick Thomas Hurley Iii, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 E Main St 2nd Floor, Springville, NY 14141 Phone: 716-592-3600 Fax: 716-592-3613 |
News Archive
Nautilus fourth quarter net sales increase 8.4% to $65.0 million
Nautilus, Inc. today reported its unaudited operating results for the fourth quarter and full year ended December 31, 2012.
Critical care nurses in poor physical and mental health report more medical errors
A study led by The Ohio State University College of Nursing finds that critical care nurses in poor physical and mental health reported significantly more medical errors than nurses in better health.
Synthetic triterpenoids block development of Parkinson's disease
A new and powerful class of antioxidants could one day be a potent treatment for Parkinson's disease, researchers report.
Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.
› Verified 6 days ago
Family Medicine
Internal Medicine
Pediatrics
Obstetrics & Gynecology
Emergency Medicine
Radiology
Ophthalmology